Horizon Technology Finance and Emalex Biosciences announced a $15 million venture loan facility to advance Emalex’s development programs through clinical trials.
Horizon Technology Finance provided a $5 million venture loan facility to Meditrina, of which $3 million has been initially funded.
Horizon Technology Finance, a specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, has provided a $20 million venture loan facility to Encore Dermatology, of which $15 million has been initially funded.
Catasys, an AI and technology-enabled healthcare company, amended and expanded its receivable facility agreement and term loan with Horizon Technology Finance to $15 million.
Horizon Technology Finance led a $10 million loan facility for MacuLogix. Horizon funded an initial $3.75 million of its commitment under the term loan facility and Silicon Valley Bank funded $1.25 million. SVB also provided a $3 million senior revolving line of credit to MacuLogix.
Catasys entered into a $10 million financing comprised of a $2.5 million receivable facility with Heritage Bank of Commerce and a four-year, $7.5 million term loan with Horizon Technology Finance.
Horizon Credit II, the subsidiary of specialty finance company Horizon Technology Finance, amended its syndicated revolving credit facility led by KeyBank.
Titan Pharmaceutical entered into a venture loan and security agreement with Horizon Technology Finance, which provides Titan with up to $10 million of available borrowing capacity.
PebblePost secured a term loan facility with Horizon Technology Finance and a secured credit facility with Silicon Valley Bank that will provide access to $27 million in funds in addition to $20 million in equity capital from institutional investors and industry angels.